Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 26,755 |
|
|||||
| News | - | ||||||
| Day High | 6.74 | Low High |
|||||
| Day Low | 6.4604 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Lipocine Inc | LPCN | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.03 | 0.46% | 6.60 | 10:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 6.59 | 6.4604 | 6.74 | 6.60 | 6.57 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 269 | 26,755 | US$ 6.58 | US$ 176,140 | - | 2.3101 - 7.15 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 09:30:30 | 2 | US$ 6.55 | USD |
Lipocine Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 34.71M | 5.32M | - | -2.85M | -16.35M | -3.08 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Lipocine News
| Date | Time | Source | News Article |
|---|---|---|---|
| 09/5/2024 | 22:00 | PR Newswire (US) | Lipocine Announces Financial Results for the First Quarter.. |
| 09/5/2024 | 20:06 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 09/5/2024 | 20:03 | Edgar (US Regulatory) | Form 8-K - Current report |
| 08/5/2024 | 22:00 | PR Newswire (US) | Lipocine Announces Late Breaking Oral Presentation of Data.. |
| 08/5/2024 | 20:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 01/5/2024 | 22:00 | PR Newswire (US) | Lipocine Announces Completion of Dosing in Pivotal Study of.. |
| 11/4/2024 | 21:00 | PR Newswire (US) | Lipocine Announces Positive LPCN 2401 Clinical Results.. |
| 28/3/2024 | 23:00 | PR Newswire (US) | Lipocine Announces Positive Week 52 Results from LPCN 1148.. |
| 25/3/2024 | 23:00 | PR Newswire (US) | Lipocine Announces First Cohort Dosed in Pivotal Study of.. |
| 08/3/2024 | 09:31 | Edgar (US Regulatory) | Form 8-K - Current report |
| 08/3/2024 | 00:00 | PR Newswire (US) | Lipocine Announces Financial Results for the Full Year Ended.. |
| 07/3/2024 | 22:08 | Edgar (US Regulatory) | Form 8-K - Current report |
Historical LPCN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.39 | 6.74 | 5.1301 | 6.10 | 34,833 | 1.21 | 22.45% |
| 1 Month | 4.79 | 6.74 | 4.38 | 5.21 | 31,150 | 1.81 | 37.79% |
| 3 Months | 3.86 | 7.15 | 3.20 | 5.75 | 70,644 | 2.74 | 70.98% |
| 6 Months | 2.48 | 7.15 | 2.38 | 5.14 | 46,687 | 4.12 | 166.13% |
| 1 Year | 3.77 | 7.15 | 2.3101 | 4.95 | 70,385 | 2.83 | 75.07% |
| 3 Years | 24.31 | 32.13 | 2.3101 | 17.91 | 349,513 | -17.71 | -72.85% |
| 5 Years | 26.52 | 59.50 | 2.3101 | 23.42 | 974,586 | -19.92 | -75.11% |
